1. Home
  2. AMIX vs CMND Comparison

AMIX vs CMND Comparison

Compare AMIX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMIX
  • CMND
  • Stock Information
  • Founded
  • AMIX 2014
  • CMND 2017
  • Country
  • AMIX United States
  • CMND Canada
  • Employees
  • AMIX N/A
  • CMND N/A
  • Industry
  • AMIX
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMIX
  • CMND Health Care
  • Exchange
  • AMIX NYSE
  • CMND Nasdaq
  • Market Cap
  • AMIX 7.3M
  • CMND 7.5M
  • IPO Year
  • AMIX N/A
  • CMND N/A
  • Fundamental
  • Price
  • AMIX $3.21
  • CMND $1.45
  • Analyst Decision
  • AMIX
  • CMND
  • Analyst Count
  • AMIX 0
  • CMND 0
  • Target Price
  • AMIX N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • AMIX 971.1K
  • CMND 2.9M
  • Earning Date
  • AMIX 02-11-2025
  • CMND 01-28-2025
  • Dividend Yield
  • AMIX N/A
  • CMND N/A
  • EPS Growth
  • AMIX N/A
  • CMND N/A
  • EPS
  • AMIX N/A
  • CMND N/A
  • Revenue
  • AMIX N/A
  • CMND N/A
  • Revenue This Year
  • AMIX N/A
  • CMND N/A
  • Revenue Next Year
  • AMIX N/A
  • CMND N/A
  • P/E Ratio
  • AMIX N/A
  • CMND N/A
  • Revenue Growth
  • AMIX N/A
  • CMND N/A
  • 52 Week Low
  • AMIX $2.55
  • CMND $0.95
  • 52 Week High
  • AMIX $152.00
  • CMND $2.30
  • Technical
  • Relative Strength Index (RSI)
  • AMIX 43.28
  • CMND 50.11
  • Support Level
  • AMIX $2.55
  • CMND $1.42
  • Resistance Level
  • AMIX $3.23
  • CMND $1.62
  • Average True Range (ATR)
  • AMIX 0.40
  • CMND 0.13
  • MACD
  • AMIX 0.19
  • CMND -0.01
  • Stochastic Oscillator
  • AMIX 41.51
  • CMND 23.08

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: